The Reputation Institute has revealed the top 10 most reputable pharma companies as voted by the general public. In a surprising result, AstraZeneca and GSK both failed to make the top 10.
Amid pressure to limit discovery losses and be more ethically responsible, the pharma industry is slowly bowing to the growing weight of evidence to find alternatives to testing on animals.
Astrazeneca and its biologics arm, Medimmune, advance in the R&D race as three new oncology drug candidates see promising developments
New research from The George Institute for Global Health discovers that despite being prescribed more often, the drug pregabalin was no better than a placebo
Ransomware attack could be wake-up call the healthcare sector needs to grasp importance of cyber security and the catastrophic cost of ignoring its threat
Pharma IQ explores the power behind medicine optimisation and the trends emerging in the pharma and healthcare market recently.
The General Data Protection Regulation (“GDPR”) applies from 25 May 2018, and introduces a new set of rules relating to the collection, storage and processing of personal data. Pharmaceutical organisations should prepare for the Regulation in order to remain compliant.
The genome-editing system based on CRISPR-Cas is becoming a valuable tool for different applications in biomedical research, drug discovery and human gene therapy by gene repair and gene disruption, gene disruption of viral sequences, and programmable RNA targeting.
Medical technologies are already addressing multiple issues and keep on developing every day. As we get more knowledge on cellular biology of DNA and RNA, new targets emerge and new therapies find place. Kira Astakhova, Associate Professor, Nucleic Acid Center at the University of Southern Denmark discusses the latest advances in small molecule drugs, formulations, and drug combinations and the ways in which they go hand in hand with biomolecular drug development.
Patient education is an important factor in disease self-management, and when handled properly it has been found to have a significant, positive impact on improving patient outcomes.